Patient perceptions of chemotherapy side-effects and the impact of 5HT3 antagonists
Author Information
Author(s): M de Boer-Dennert, R de Wit, PIM Schmitz, J Djontono, V v Beurden, G Stoter, J Verweijl
Primary Institution: Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital, Rotterdam, The Netherlands
Hypothesis
The study aims to evaluate the impact of 5HT3 antagonists on patient perceptions of the side-effects of chemotherapy.
Conclusion
Despite the use of 5HT3 antagonists, nausea and vomiting remain the most distressing side-effects of chemotherapy for patients.
Supporting Evidence
- Nausea and vomiting were ranked as the first and third most distressing side-effects of chemotherapy.
- 80% of patients experienced nausea and 57% experienced vomiting.
- Hair loss was more distressing for women compared to men.
- Constipation was ranked as a new distressing side-effect compared to previous studies.
Takeaway
Patients undergoing chemotherapy still find nausea and vomiting very distressing, even with new medications that help reduce these side-effects.
Methodology
Patients ranked their side-effects in order of distress using a questionnaire based on a previous survey.
Potential Biases
Health care workers may overestimate the effectiveness of antiemetic treatments based on acute emesis data.
Limitations
The study may not fully capture the long-term effects of chemotherapy on patient perceptions.
Participant Demographics
181 evaluable patients, 101 male and 80 female, mean age 50 years (range 18-78).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website